Allspring Global Investments Holdings, LLC Citius Pharmaceuticals, Inc. Transaction History

Allspring Global Investments Holdings, LLC

  • $62.2 Billion
  • Q1 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 27, 2023
BUY
$0.65 - $1.25 $72,428 - $139,285
111,428 New
111,428 $75,000
Q2 2022

Jul 25, 2022
SELL
$0.88 - $1.87 $456,319 - $969,679
-518,545 Closed
0 $0
Q1 2022

May 02, 2022
SELL
$1.38 - $1.89 $4,104 - $5,620
-2,974 Reduced 0.57%
518,545 $928,000
Q4 2021

Jan 28, 2022
BUY
$1.51 - $2.2 $787,493 - $1.15 Million
521,519 New
521,519 $803,000

Others Institutions Holding CTXR

# of Institutions
73
Shares Held
26.8M
Call Options Held
0
Put Options Held
0
View Full List

About Citius Pharmaceuticals, Inc.

CTXR Quotes by TradingView
  • Ticker CTXR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 146,130,000
  • Market Cap $99.4M
  • Description
  • Citius Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the development and commercialization of critical care products focusing on anti-infective products in adjunct cancer care, prescription products, and mesenchymal stem cell therapy. The company is developing five proprietary products comprising Mino-Lok, an antibiotic l...
More about CTXR
Track This Portfolio

Track Allspring Global Investments Holdings, LLC Portfolio

Follow Allspring Global Investments Holdings, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Allspring Global Investments Holdings, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Allspring Global Investments Holdings, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email